Form 4: Guardant Health Director Myrtle S. Potter Reports Stock Transaction

Director Myrtle S. Potter reports a transaction involving Guardant Health, Inc. common stock on March 15, 2025.

Summary

• On March 15, 2025, Myrtle S. Potter, a director of Guardant Health, Inc., reported a transaction involving the company's common stock.
• The transaction involved the vesting of restricted stock units, resulting in the acquisition of 69 shares of common stock at a price of $0.
• Following the transaction, Potter directly owns 13,927 shares of Guardant Health, Inc. common stock.
• The restricted stock units vest 25% on October 15, 2022, and the remaining 75% vests in equal monthly installments over three years.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a routine stock transaction. It doesn't inherently convey positive or negative sentiment.

Positives

• The vesting of restricted stock units suggests continued alignment of the director's interests with the company's performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. This filing indicates the vesting of previously granted equity compensation.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders, as it reflects the vesting of previously granted equity compensation.

Key Dates